Carbiotix AB

As of September 30, 2025, Carbiotix AB has 4.98M shares outstanding.

These figures are as of September 30, 2025. The price-to-sales ratio is 24.99, and the price-to-book ratio stands at -0.24.

These figures are as of September 30, 2025. The EV/Sales ratio of 24.31 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

As of September 30, 2025, Carbiotix AB maintains a current ratio of 1.19, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended September 30, 2025. Return on assets (ROA) is negative at -54.77, reflecting losses generated across the asset base.

Over the twelve months ended September 30, 2025, Carbiotix AB posted a gross margin of 296.12, reflecting its pricing power and cost economics. The operating margin of -1,584.36 and net profit margin of -1,632.30 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2025. Free cash flow yield is negative at -54.28: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -51.72, meaning Carbiotix AB raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Carbiotix AB's most recent stock split took place on September 17, 2024 with a 100:1 split ratio.

As of September 30, 2025, Carbiotix AB has an Altman Z-Score of -56.04, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.